Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 20 2024
0mins
Source: Globenewswire
Collaboration Announcement: Celularity is partnering with Genting Berhad to introduce placenta-derived stem cell therapies in the Asia Pacific region, starting with a new wellness center in Bali, Indonesia, expected to open by late 2026.
Market Potential: The Asia Pacific stem cell market is projected to grow significantly, reaching USD 7.2 billion by 2030, driven by increasing investments in regenerative medicine and the demand for innovative therapies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
